Creative Biolabs-Immuno-oncology

Anti-CD70 (clone Hll1G) SynExpress E1-G-I10-K Modified CD8+ T cells (CAT#: ITS-1224-CR1792)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD70 (clone Hll1G). We employs the pGEM (EF1α-GFP-IL-10-KpnI) vector components and the SynExpress system of the Exons Inversion/Negative feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD70
Clone
Hll1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
EF1α
Effector Gene
IL-10
Insertion Sites
KpnI
Gene Modification
Inversion
Modification Domain
Exons
Carrier Type
pGEM
Transformation Accuracy
0.95
Cell Culture
Suspension Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.